Alexandra Baaske
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexandra Baaske has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Amy Booth
Women's Health Research Institute, Vancouver, BC; School of Population and Public Health, University of British Columbia, Vancouver, BC
2 shared publicationsAngela Kaida
Women's Health Research Institute, Vancouver, BC; Faculty of Health Sciences, Simon Fraser University, Burnaby, BC
1 shared publication- Angela Kaida
Simon Fraser University, Burnaby, Canada
1 shared publication Anna Gottschlich
Women's Health Research Institute, Vancouver, BC; School of Population and Public Health, University of British Columbia, Vancouver, BC
1 shared publication- Anna Gottschlich
Women’s Health Research Institute, BC Women’s Hospital and Health Services, Vancouver, British Columbia, Canada
1 shared publication - Arianne Albert
Women’s Health Research Institute, Vancouver, Canada
1 shared publication
Latest Publications
- Open Access
- 4 July 2025
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 55 (11) , 1083-1092
Preschool Oral Immunotherapy Is Associated With Improved Parental Food Allergy‐Specific Anxiety and Quality of Life: A Real‐World Observational Study
Introduction: Preschool oral immunotherapy (OIT) is safe and effective for food allergy, and may improve parental food allergy‐specific anxiety (FAA) and food allergy quality of life (FAQL); however, data on these important outcomes are limited, particularly for preschoolers. Herein, we explored the relationship between OIT and parental FAA, including the subdomains: food allergy‐related worries, anxiety impact, behavioural avoidance, and coping; and OIT and FAQL in parents of preschool‐aged children. Methods: Parents of preschool‐aged children (< 72 months) receiving OIT in Canadian allergy clinics were eligible for this observational study. The Impairment Measure for Parental Food Allergy‐Associated Anxiety and Coping Tool (IMPAACT) and the Food Allergy Quality of Life—Parental Burden (FAQL‐PB) questionnaire were administered to parents at four timepoints from the start of OIT to 12 months post‐build‐up. The relationships between OIT and total FAA, each IMPAACT subscale, and FAQL were investigated using a series of linear mixed effect models. Each model included variables related to child age, whether child was receiving OIT to some (partial OIT) or all of (complete OIT) their allergens, time to complete build‐up, and two binary variables indexing whether the child experienced a reaction during build‐up or maintenance. Results: Between 2021 and 2025, 788 children participated. Total IMPAACT scores decreased during OIT build‐up, indicating improvement (baseline: 70.69; end of build‐up: 57.36; marginal mean change: −13.33; b = −18.13; 95% CI = −27.63, −8.62, p < 0.001). IMPAACT scores significantly decreased across three subscales: Worries; anxiety impact, and behavioural avoidance. FAQL‐PB scores decreased during OIT build‐up (baseline: 27.35; end of build‐up: 22.16; marginal mean change: −5.19; b = −7.17; 95% CI = −12.65, −1.69, p = 0.01). Child's age, partial versus complete OIT, time to complete build‐up, and reactions during maintenance moderated the relationship between time and some of the outcome variables. Conclusion: Preschool OIT is associated with significant improvements in parent food allergy‐specific anxiety and food allergy quality of life.
- 4 July 2025
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 55 (11) , 1083-1092
Open AccessPreschool Oral Immunotherapy Is Associated With Improved Parental Food Allergy‐Specific Anxiety and Quality of Life: A Real‐World Observational Study
Introduction: Preschool oral immunotherapy (OIT) is safe and effective for food allergy, and may improve parental food allergy‐specific anxiety (FAA) and food allergy quality of life (FAQL); however, data on these important outcomes are limited, particularly for preschoolers. Herein, we explored the relationship between OIT and parental FAA, including the subdomains: food allergy‐related worries, anxiety impact, behavioural avoidance, and coping; and OIT and FAQL in parents of preschool‐aged children. Methods: Parents of preschool‐aged children (< 72 months) receiving OIT in Canadian allergy clinics were eligible for this observational study. The Impairment Measure for Parental Food Allergy‐Associated Anxiety and Coping Tool (IMPAACT) and the Food Allergy Quality of Life—Parental Burden (FAQL‐PB) questionnaire were administered to parents at four timepoints from the start of OIT to 12 months post‐build‐up. The relationships between OIT and total FAA, each IMPAACT subscale, and FAQL were investigated using a series of linear mixed effect models. Each model included variables related to child age, whether child was receiving OIT to some (partial OIT) or all of (complete OIT) their allergens, time to complete build‐up, and two binary variables indexing whether the child experienced a reaction during build‐up or maintenance. Results: Between 2021 and 2025, 788 children participated. Total IMPAACT scores decreased during OIT build‐up, indicating improvement (baseline: 70.69; end of build‐up: 57.36; marginal mean change: −13.33; b = −18.13; 95% CI = −27.63, −8.62, p < 0.001). IMPAACT scores significantly decreased across three subscales: Worries; anxiety impact, and behavioural avoidance. FAQL‐PB scores decreased during OIT build‐up (baseline: 27.35; end of build‐up: 22.16; marginal mean change: −5.19; b = −7.17; 95% CI = −12.65, −1.69, p = 0.01). Child's age, partial versus complete OIT, time to complete build‐up, and reactions during maintenance moderated the relationship between time and some of the outcome variables. Conclusion: Preschool OIT is associated with significant improvements in parent food allergy‐specific anxiety and food allergy quality of life.
- 20 June 2022
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 44 (10) , 1076-1083
Barriers To Accessing Contraception and Cervical and Breast Cancer Screening During COVID-19: A Prospective Cohort Study
- 20 June 2022
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 44 (10) , 1076-1083
Barriers To Accessing Contraception and Cervical and Breast Cancer Screening During COVID-19: A Prospective Cohort Study
- Open Access
The influence of sex, gender, age, and ethnicity on psychosocial factors and substance use throughout phases of the COVID-19 pandemic
The SARS-CoV-2 (COVID-19) pandemic has had profound physical and mental health effects on populations around the world. Limited empirical research has used a gender-based lens to evaluate the mental health impacts of the pandemic, overlooking the impact of public health measures on marginalized groups, such as women, and the gender diverse community. This study used a gender-based analysis to determine the prevalence of psychosocial symptoms and substance use by age, ethnicity, income, rurality, education level, Indigenous status, and sexual orientation. Participants in the study were recruited from previously established cohorts as a part of the COVID-19 Rapid Evidence Study of a Provincial Population-Based Cohort for Gender and Sex (RESPPONSE) study. Those who agreed to participate were asked to self-report symptoms of depression, anxiety, pandemic stress, loneliness, alcohol use, and cannabis use across five phases of the pandemic as well as retrospectively before the pandemic. For all psychosocial outcomes, there was a significant effect of time with all five phases of the pandemic being associated with more psychosocial symptoms relative to pre-COVID levels ( p < .0001). Gender was significantly associated with all outcomes ( p < .0001) with men exhibiting lower scores (i.e., less symptoms) than women and gender diverse participants, and women exhibiting lower scores than the gender diverse group. Other significant predictors were age (younger populations experiencing more symptoms, p < .0001), ethnicity (Chinese/Taiwanese individuals experiencing less symptoms, p = .005), and Indigenous status (Indigenous individuals experiencing more symptoms, p < .0001). Alcohol use and cannabis use increased relative to pre-pandemic levels, and women reported a greater increase in cannabis use than men ( p < .0001). Our findings highlight the need for policy makers and leaders to proactively consider gender when tailoring public health measures for future pandemics.
Open AccessThe influence of sex, gender, age, and ethnicity on psychosocial factors and substance use throughout phases of the COVID-19 pandemic
The SARS-CoV-2 (COVID-19) pandemic has had profound physical and mental health effects on populations around the world. Limited empirical research has used a gender-based lens to evaluate the mental health impacts of the pandemic, overlooking the impact of public health measures on marginalized groups, such as women, and the gender diverse community. This study used a gender-based analysis to determine the prevalence of psychosocial symptoms and substance use by age, ethnicity, income, rurality, education level, Indigenous status, and sexual orientation. Participants in the study were recruited from previously established cohorts as a part of the COVID-19 Rapid Evidence Study of a Provincial Population-Based Cohort for Gender and Sex (RESPPONSE) study. Those who agreed to participate were asked to self-report symptoms of depression, anxiety, pandemic stress, loneliness, alcohol use, and cannabis use across five phases of the pandemic as well as retrospectively before the pandemic. For all psychosocial outcomes, there was a significant effect of time with all five phases of the pandemic being associated with more psychosocial symptoms relative to pre-COVID levels ( p < .0001). Gender was significantly associated with all outcomes ( p < .0001) with men exhibiting lower scores (i.e., less symptoms) than women and gender diverse participants, and women exhibiting lower scores than the gender diverse group. Other significant predictors were age (younger populations experiencing more symptoms, p < .0001), ethnicity (Chinese/Taiwanese individuals experiencing less symptoms, p = .005), and Indigenous status (Indigenous individuals experiencing more symptoms, p < .0001). Alcohol use and cannabis use increased relative to pre-pandemic levels, and women reported a greater increase in cannabis use than men ( p < .0001). Our findings highlight the need for policy makers and leaders to proactively consider gender when tailoring public health measures for future pandemics.